The pharmacy day | A question to investigate
The unavailable item is only the visible part
A medicines supply problem can generate ordering checks, calls, explanations, repeat visits and professional decisions across several organisations. A stock report may show the item, while none of those systems captures the whole effort of managing the consequence. For a pharmacy owner, the useful question is which part of that work is avoidable, which requires professional judgement and what can be changed locally without making someone else's problem harder.
In the conversation.
NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.
Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.
Separate a supply issue from a local stock decision
An item not currently on the shelf is not necessarily a national shortage. An outstanding order, uncertain availability, a discontinued presentation and a prescription requiring clarification create different next steps. NHS SPS provides professional resources for managing supply issues (NHS SPS, n.d.). An evaluation should classify the operational issue accurately and refer to current authoritative information, rather than infer availability or recommend clinical substitutions from a historical dispensing dataset.
Map effort across the whole episode
Record the categories of work involved: checking supply, contacting the prescriber, explaining the situation, handling an owing and arranging the next action. Use staff-agreed categories and aggregate time estimates for an initial assessment. Do not needlessly copy prescription details into a separate system. The pattern matters: one issue can produce several contacts, and a task moved from the pharmacy to the GP practice is not necessarily removed from the pathway.
Choose an intervention within the pharmacy's control
A proposed first test could address a repeated non-clinical coordination problem, such as duplicated checking of the same outstanding order or unclear ownership of the next update. Compare ordinary practice with a shared, locally approved handover process. Clinical decisions about alternative treatment, supply under an applicable protocol or urgency would remain with the responsible professionals. PHARMORIS should not be marketed as an autonomous replacement for that judgement or for current national shortage resources.
Build a work account around the supply issue
For an agreed category of supply problem, show number of episodes, contacts per episode, handling effort, unresolved duration and recorded next owner. Add stock purchased and actual acquisition cost only where relevant and authorised. This distinguishes coordination effort from inventory investment. It also exposes an apparent improvement that reduces pharmacy contacts only by increasing calls to the practice, or moves cost into stock without resolving the underlying uncertainty.
Find the gap between organisations.
A useful handover is information that reaches someone able to act. Explore a constructed case before deciding what to measure.
One supply issue generates several repeat contacts.
Makes a shared operational problem inspectable without claiming that referral volume proves prevented readmissions.
What would we need to understand?
- Episodes entering the defined cohort
- Agreed handovers and recorded progression
- Elapsed time bands and reasons for waiting
- Clarification effort and accountable next owner
Constructed decision example | No customer results are shown.
Account for stock and cash carefully
Holding more stock may reduce some local inconvenience while increasing working capital, expiry exposure and storage demands. Reimbursement information is relevant to the financial account, but a published price is not the same as the pharmacy's actual acquisition cost. Compare options using authorised local cost data and realistic uncertainty about demand. Avoid a business case that counts increased inventory as a solution without considering how the owner will fund it and what happens if demand changes.
Evaluate experience as well as handling time
A faster internal task is useful only if the overall episode becomes clearer. Track repeat enquiries, unresolved cases and whether the next step was communicated appropriately. Do not imply a change in medicine availability when the intervention only changed communication. A short operational review could establish reduced duplicated effort or more reliable case ownership; it cannot establish improved clinical outcomes, national resilience or a reduction in the underlying rate of medicine shortages.
Know when the comparison is no longer valid
Supply conditions may change during an evaluation, making one period materially different from another. Record those changes and avoid attributing recovery to a local process when availability improved independently. Stop if a proposed workflow obscures urgent needs, creates unsafe delay or encourages unauthorised substitution. A mixed result may still identify a valuable boundary: the work the pharmacy can simplify and the problem that requires action by a prescriber, supplier or national body.
NEUVIOR Data Analysis
A source.
A question.
A clearer decision.
Useful intelligence keeps its evidence attached.
Our public analysis connects a defined question with named sources, reporting periods and methods. Each source below shows the work available today and the access still needed.
Published-data analysis, research hypotheses and evidence studies are distinct kinds of work. Their meaning should remain clear as the programme grows.
NHS Business Services Authority | Annual
Prescription Cost Analysis
How does activity differ from ingredient-cost concentration?
Analysis availableNHS Business Services Authority | Monthly
English Prescribing Dataset with SNOMED Code
Which product and organisational patterns merit a closer investigation?
Metadata retrievedMedicines and Healthcare products Regulatory Agency | Event-driven; monthly roundup also published
Medicines and device safety communications
Which official communication should a responsible team read next?
Snapshot retrievedNHS Business Services Authority and NHS England | Weekly
Dictionary of medicines and devices
Can the same product identity be followed consistently across sources?
Access reviewBring the repeated work, not a promise of perfect supply
The most useful first conversation concerns a recurring category of supply issue and the decision it prevents the team making. We can explore whether a bounded intelligence use case would help organise evidence, ownership and review. The ambition is practical: a clearer response to uncertainty, less duplicated coordination and an economic account that respects the difference between working capital, staff capacity and genuinely improved access to medicines.
Sources and scope
NHS SPS | Managing medicines supply issues | NHSBSA | Payments and pricing
NHS SPS (n.d.) Managing medicines supply issues. Available at: https://www.sps.nhs.uk/wp-content/uploads/2025/11/Managing-medicines-supply-issues-poster.pdf (Accessed: 14 October 2026).
Another useful angle.
- Inclusive pharmacy access | Understand who cannot use the journey
Evaluate communication needs, booking barriers and service access without treating digital uptake as the only success measure.
- New Medicine Service | Make follow-up workable
A practical evaluation of NMS follow-up scheduling, contact effort and continuity without promising clinical outcomes.
- Supermarket pharmacies | Turn access into a coherent service
Explore the operational questions between supermarket footfall, pharmacy enquiries, clinical capacity and completed services.